Eli Lilly and Company
LLY
주식 순위
#12
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to... Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.
주가
$1,256.39
마지막 동기화: 2026-10-16
시가총액
$1.183T
변동 (1일)
0.26%
변동 (1년)
58.45%
국가
US
거래 Eli Lilly and Company (LLY)
카테고리
Healthcare
Eli Lilly and Company (LLY)의 영업이익률
February 2026 기준 영업이익률 TTM: 45.56%
Eli Lilly and Company의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 45.56%입니다. 2024년 말 기준 영업이익률은 38.86%였습니다.
Eli Lilly and Company의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 45.56% | 0.00% |
| 2025 | 45.56% | 17.24% |
| 2024 | 38.86% | 22.94% |
| 2023 | 31.61% | 4.25% |
| 2022 | 30.32% | 8.25% |
| 2021 | 28.01% | -4.66% |
| 2020 | 29.38% | 9.30% |
| 2019 | 26.88% | -4.14% |
| 2018 | 28.04% | 31.77% |
| 2017 | 21.28% | 16.67% |
| 2016 | 18.24% | 1.33% |
| 2015 | 18.00% | 6.07% |
| 2014 | 16.97% | -29.29% |
| 2013 | 24.00% | 8.16% |
| 2012 | 22.19% | -14.69% |
| 2011 | 26.01% | -11.38% |
| 2010 | 29.35% | 0.62% |
| 2009 | 29.17% | 7.52% |
| 2008 | 27.13% | 5.24% |
| 2007 | 25.78% | -1.94% |
| 2006 | 26.29% | 5.54% |
| 2005 | 24.91% | -5.64% |
| 2004 | 26.40% | -5.14% |
| 2003 | 27.83% | -7.36% |
| 2002 | 30.04% | -7.03% |
| 2001 | 32.31% | -1.40% |
| 2000 | 32.77% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 25.70% | -99.44% |
US
|
|
| 29.32% | -99.36% |
US
|
|
| 26.59% | -99.42% |
CH
|
|
| 16.65% | -99.63% |
US
|
|
| 31.24% | -99.31% |
CH
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.